Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan H Schefe

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|March 13, 2008
PLZF and the (pro)renin receptorJan H Schefe, Thomas Unger, Heiko Funke-Kaiser
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 17, 2009
Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damageHeiko Funke-Kaiser, Frank S Zollmann, Jan H Schefe, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 15, 2006
Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formulaJan H Schefe, Kerstin E Lehmann, Ivo R Buschmann, et al.
European Journal of Hospital Pharmacy : Science and Practice|July 19, 2022
Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vialsMona Abdel-Tawab, Markus Waßmuth, Florian Gegenfurtner, et al.
Brain Research|April 2, 2008
Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brainKristin Schmerbach, Jan H Schefe, Maxim Krikov, et al.
Journal of Hypertension|August 14, 2008
Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskirenJan H Schefe, Christian Neumann, Matthias Goebel, et al.
Anticancer Research|May 18, 2012
Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitroHongyu Liu, Christian Scholz, Chuanbing Zang, et al.
Onkologie|November 23, 2011
Primary tumor excision in stage IV breast cancer at diagnosis without influence on survival: a retrospective analysis and review of the literatureMarleen Rosche, Anne-Constanze Regierer, Sandra Schwarzlose-Schwarck, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2004
Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi proteinChristoph J Wruck, Heiko Funke-Kaiser, Thomas Pufe, et al.
Circulation Research|November 4, 2006
A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger proteinJan H Schefe, Mario Menk, Jana Reinemund, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Molecular Medicine (Berlin, Germany)|March 13, 2008
PLZF and the (pro)renin receptorJan H Schefe, Thomas Unger, Heiko Funke-Kaiser
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 17, 2009
Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damageHeiko Funke-Kaiser, Frank S Zollmann, Jan H Schefe, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 15, 2006
Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formulaJan H Schefe, Kerstin E Lehmann, Ivo R Buschmann, et al.
European Journal of Hospital Pharmacy : Science and Practice|July 19, 2022
Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vialsMona Abdel-Tawab, Markus Waßmuth, Florian Gegenfurtner, et al.
Brain Research|April 2, 2008
Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brainKristin Schmerbach, Jan H Schefe, Maxim Krikov, et al.
Journal of Hypertension|August 14, 2008
Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskirenJan H Schefe, Christian Neumann, Matthias Goebel, et al.
Anticancer Research|May 18, 2012
Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitroHongyu Liu, Christian Scholz, Chuanbing Zang, et al.
Onkologie|November 23, 2011
Primary tumor excision in stage IV breast cancer at diagnosis without influence on survival: a retrospective analysis and review of the literatureMarleen Rosche, Anne-Constanze Regierer, Sandra Schwarzlose-Schwarck, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2004
Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi proteinChristoph J Wruck, Heiko Funke-Kaiser, Thomas Pufe, et al.
Circulation Research|November 4, 2006
A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger proteinJan H Schefe, Mario Menk, Jana Reinemund, et al.
Pageof 2